CenExel Clinical Research Acquires CITrials
March 9, 2021
CenExel Clinical Research, a U.S.-based network of clinical research sites, has acquired CITrials, a Southern California clinical research firm operating three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. The acquisition expands CenExel's capacity and capabilities in psychiatric and neurological (CNS) research and enables greater integration with its other Southern California operations.
- Targets
- CITrials
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BayPine to Acquire CenExel Clinical Research
April 14, 2025
Healthcare Services
BayPine entered into a definitive agreement to acquire CenExel Clinical Research, a nationwide clinical trial site network focused on complex therapeutic areas. After closing, BayPine will be the majority investor in CenExel alongside Webster Equity Partners, which will retain a minority stake, with management continuing to hold equity.
-
CenExel Acquires iResearch
May 3, 2022
Healthcare Services
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
-
CenExel Clinical Research Acquires CTSdatabase
February 22, 2022
Healthcare Services
CenExel Clinical Research has acquired CTSdatabase, a global duplicate-subject detection and clinical trial registry led by Dr. Thomas M. Shiovitz. The acquisition integrates CTSdatabase's subject-detection capabilities into CenExel's site network to improve data quality across clinical trials while CTSdatabase will continue to operate independently and support external sponsors and CROs.
-
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022
Healthcare Services
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
CenExel Clinical Research Acquires Advanced Memory Research Institute
August 19, 2021
Healthcare Services
CenExel Clinical Research, Inc. has acquired Advanced Memory Research Institute (CenExel AMRI), the largest Alzheimer's Disease clinical research site in the U.S. Northeast. The deal expands CenExel's CNS and Alzheimer's trial capabilities by integrating AMRI into its Centers of Excellence network; Provident Healthcare Partners served as exclusive sell-side financial advisor.
-
CenExel Acquires ForCare Clinical Research
August 4, 2021
Healthcare Services
CenExel Clinical Research has acquired Tampa-based ForCare Clinical Research, adding a dermatology- and immunology-focused clinical research site to its Centers of Excellence network. The addition strengthens CenExel's capabilities to conduct Phase I–IV trials across dermatology, immunology and other therapeutic areas and will integrate ForCare into CenExel's centralized operations and quality systems. Provident Healthcare Partners served as exclusive sell-side financial advisor to ForCare in the transaction.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.